Non-autologous transplantation with immuno-isolation in large animals - A review

Annals of the New York Academy of Sciences

Volumn 831, Issue , 1997, Pages 408-426

  Stockley, Tracy L ^a   Chang, Patricia L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; ENDOCRINE DISEASE; GENE THERAPY; GENETIC DISORDER; IMMUNE SYSTEM; NEUROLOGIC DISEASE; NONHUMAN; ORGAN TRANSPLANTATION; RECOMBINANT GENE;

ANIMALIA; OVIS ARIES; PRIMATES; RODENTIA;

EID: 0031593227     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52214.x     Document Type: Conference Paper

References (83)

1. CATTO, G. R. C., Ed. 1987. Clinical Transplantation. Current Practice and Future Prospects. MTP Press. Boston.
2. PLATT, J. L., G. M. VERCELLOTTI, A. P. DALMASSO, A. J. MATAS, R. M. BOLMAN, J. S. NAJARIAN & F. H. BACH. 1990. Transplantation of discordant xenografts: A review of progress. Immunol. Today 11: 450-456.
3. BOREL, J. F. & H. C. GUNN. 1986. Cyclosporine as a new approach to therapy of autoimmune disease. Ann. N. Y. Acad Sci. 475: 307-318.
4. GLOVER, S. 1987. Problems of the immunosuppressed patient. In Clinical Transplantation. Current Practice and Future Prospects. G. R. C. Catto, Ed. MTP Press. Boston.
5. FODOR, W. L., B. L. WILLIAMS, L. A. MATIS, J. A. MAORI, S. A. ROLLINS, J. W. KNIGHT, W. VELANDER & S. P. SQUINTO. 1994. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc. Natl. Acad. Sci. USA 91: 11153-11157.
6. SANDRIN, M. S. & I. F. C. MCKENZIE. 1994. Gal (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol. Rev. 141: 170-190.
7. WILLIAMS, N. 1997. Pig-human transplants barred for now. Science 275: 473.
8. LANZA, R. P., J. L. HAYES & W. L. CHICK. 1996. Encapsulated cell technology. Nat. Biotech. 14: 1107-1111.
9. LANZA, R. P. & W. L. CHICK. 1997. Immunoisolation: At a turning point. Immunol. Today 18: 135-139.
10. LYSAGHT, M. J., B. FRYDEL, F. GENTILE, D. EMERICH & S. WINN. 1994. Recent progress in immunoisolated cell therapy. J. Cell. Biochem. 56: 196-203.
11. CHANG, T. M. S. 1964. Semipermeable microcapsules. Science 146: 524-525.
12. LANZA, R. P. & W. L. CHICK. 1997. Transplantation of encapsulated cells and tissues. Surgery 121: 1-9.
13. LANZA, R. P. & W. L. CHICK. 1995a. Encapsulated cell transplantation. Transplant Rev. 9: 217-230.
14. LANZA, R. P. & W. L. CHICK. 1995b. Encapsulated cell therapy. Sci. Am., July, 16-25.
15. LACY, P. E. 1995. Treating diabetes with transplanted cells. Sci. Am., July, 50-58.
16. LACY, P. E. 1995. Islet cell transplantation for insulin-dependent diabetes. Hospital Practice, June, 41-45.
17. LANZA, R. P. & W. L. CHICK. 1996/1996. Pancreas. In Yearbook of Cell and Tissue Transplantation, R. P. Lanza & W. L. Chick, Eds.: 253-264. Kluwer Academic Publishers. Netherlands.
18. SULLIVAN, S. J., T. MAKI, K. M. BORLAND, M. D. MAHONEY, B. A. SOLOMON, T. E. MULLER, A. P. MONACO & W. L. CHICK. 1991. Biohybrid artificial pancreas: long term implantation studies in diabetic, pancreatectomized dogs. Science 252: 718-721.
19. COLTON, C. K. & E. S. AVGOUSTINIATOS. 1991. Bioengineering in development of the hybrid artificial pancreas. J. Biomech. Eng. 113: 152-170.
20. LANZA, R. P., K. M. BORLAND, P. LODGE, M. CARRETTA, S. J. SULLIVAN, T. E. MULLER, B. A. SOLOMON, T. MAKI, A. P. MONACO & W. L. CHICK. 1992a. Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 41: 886-889.
21. LANZA, R. P., P. LODGE, K. M. BORLAND, M. CARRETTA, S. J. SULLIVAN, A. M. BEYER, T. E. MULLER, B. A. SOLOMON, T. MAKI, A. P. MONACO & W. L. CHICK. 1993. Transplantation of islet allografts using a diffusion-based biohybrid artificial pancreas: Long-term studies in diabetic, pancreatectomized dogs. Transplant. Proc. 25: 978-980.
22. LIM, F. & A. M. SUN. 1980. Microencapsulated islets as bioartificial endocrine pancreas. Science 210: 908-910.
23. WINN, S. R. & P. A. TRESCO. 1994. Hydrogel applications for encapsulated cellular transplants. Meth. Neurosci. 21: 387-402.
24. SEFTON, M. V., L. KHARLIP, V. HORVATH & T. ROBERTS. 1992. Controlled release using microencapsulated mammalian cells. J. Controlled Release 19: 289-298.
25. COHEN, S., M. C. BANO, K. B. VISSCHER, M. CHOW, H. R. ALLCOCK & R. LANGER. 1990. Ionically cross-linkable polyphosphazene: a novel polymer for microencapsulation. J. Am. Chem. Soc. 112: 7832-7833.
26. LIM, F. & R. D. MOSS. 1981. Microencapsulation of living cells and tissues. J. Pharm. Sci. 70: 351-354.
27. CALAFIORE, R. 1992. Transplantation of microencapsulated pancreatic human islets for therapy of diabetes mellitus. ASAIO J. 38: 34-37.
28. SOON-SHIONG, P., M. OTTERLIE, O. SKJAK-BRAEK, O. SMIDSROD, R. HEINTA, R. P. LANZA & T. ESPEVIK. 1991. An immunological basis for the fibrotic reaction to implanted microcapsules. Transplant. Proc. 23: 758-759.
29. SOON-SHIONG, P., E. FELDMAN, R. NELSON, R. HEINTZ, N. MERIDETH, P. A. SANDFORD, T. ZHENG & J. KOMTEBEDDE. 1992. Long-term reversal of diabetes in the large animal model by encapsulated islet transplantation. Transplant. Proc. 24: 2946-2947.
30. SOON-SHIONG, P., E. FELDMAN, R. NELSON, J. KOMTEBEDDE, O. SMIDSROD, G. SKJAK-BRAEK, T. EXPEVIK, R. HEINTZ & M. LEE. 1992. Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 54: 769-774.
31. SOON-SHIONG, P., E. FELDMAN, R. NELSON, R. HEINTZ, Q. YAO, Z. YAO, T. ZHENG, N. MERIDETH, G. SKJAK-BRAEK, T. EXPEVIK, O. SMIDSROD & P. SANDFORD. 1993. Long-term reversal of diabetes by the injection of immunoprotected islets. Proc. Natl. Acad. Sci. USA 90: 5843-5847.
32. SUN, Y., X. MA, D. ZHOU, I. VACEK & A. M. SUN. 1996. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J. Clin. Invest. 98: 1417-1422.
33. LANZA, R. P., D. H. BUTLER, K. M. BORLAND, J. M. HARVEY, D. L. FAUSTMAN, B. A. SOLOMON, T. E. MULLER, R. G. RUPP, T. MAKI, A. P. MONACO & W. L. CHICK. 1992b. Successful xenotransplantation of a diffusion-based biohybrid artificial pancreas: A study using canine, bovine and porcine islets. Transplant. Proc. 24: 669-671.
34. LANZA, R. P., W. M. KUHTREIBER, D. M. ECKER, J. P. MARSH & W. L. CHICK. 1995a. Transplantation of porcine and bovine islets into mice without immunosuppression using uncoated alginate microspheres. Transplant. Proc. 27: 3321.
35. LANZA, R. P., W. M. KUHTREIBER, D. M. ECKER, J. P. MARSH & W. L. CHICK. 1995b. Successful bovine islet xenografts in rodents and dogs using injectable microreaders. Transplant. Proc. 27: 3211.
36. SOON-SHIONG, P., R. E. HEINTZ, N. MERIDETH, Q. X. YAO, Z. YAO, T. ZHENG, M. MURPHY, M. K. MOLONEY, M. SCHMEHL, M. HARRIS, R. MENDEZ, R. MENDEZ & P. A. SANDFORD. 1994. Insulin independence in a type I diabetic patient after encapsulated islet transplantation. Lancet 343: 950-951.
37. SCHARP, D. W., C. J. SWANSON, B. J. OLACK, P. P. LATTA, O. D. HEGRE, E. J. DOHERTY, F. T. GENTILE, K. S. FLAVIN, M. F. ANSARA & P. E. LACY. 1994. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 43: 1167-1170.
38. VIRORX. 1997. Beta cell encapsulation. Internet site: http://www.diabetes.com/betacl. html
39. DARQUY, S. & A. M. SUN. 1987. Microencapsulation of parathyroid cells as a bioartificial parathyroid. Trans. Am. Soc. Artif. Intern. Organs XXXII: 356-538.
40. FU, X. W. & A. M. SUN. 1989. Microencapsulated parathyroid cells as a bioartificial parathyroid. Transplantation 47: 432-435.
41. LIM, F. 1984. Microencapsulation of living cells and tissues - theory and practice. In Biomedical Applications of Microencapsulation. F. Lim, Ed.: 137-154. CRC Press. Boca Raton, FL.
42. AEBISCHER, P., S. R. WINN & P. M. GALLETTI. 1991a. Transplantation of neural tissue in polymer capsules. Brain Res. 448: 364-368.
43. WINN, S. R., P. A. TRESCO, B. ZIELINSKI, L. A. GREENE, C. B. JAEGER & P. AEBISCHER. 1991. Behavioural recovery following intrastriatal implantation of microencapsulated PC12 cells. Exp. Neurol. 113: 322-329.
44. AEBISCHER, P., P. A. TRESCO, J. SAGEN & S. R. WINN. 1991. Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats. Brain Res. 560: 43-49.
45. AEBISCHER, P., M. GODDARD, A. P. SIGNORE & R. L. TIMPSON. 1994. Functional recovery in hemiparksonian primates transplanted with polymer-encapsulated PC12 cells. Exp. Neurol. 126: 151-158.
46. AEBISCHER, P., M. SCHLUEP, N. DEGLON, J.-M. JOSEPH, L. HIRT, B. HEYD, M. GODDARD, J. P. HAMMANG, A. D. ZURN, A. C. KATO, F. REGLI & E. E. BAETGE. 1996. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 2: 696-699.
47. SAGEN, J. 1992. Chromaffin cell transplants for alleviation of chronic pain. ASAIO J. 38: 24-28.
48. SAGEN, J., H. WANG, P. A. TRESCO & P. AEBISCHER. 1993. Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances. J Neurosci. 13: 2415-2423.
49. AEBISCHER, P., P. A. TRESCO, S. R. WINN, L. A. GREENE & C. B. JAEGER. 1991. Long-term cross species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Exp. Neurol. 111: 269-275.
50. SAGEN, J. & G. D. PAPPAS. 1987. Morphological and functional correlates of chromaffin cell transplants in CNS pain modulatory regions. Ann. N. Y. Acad. Sci. 495: 306-333.
51. JOSEPH, J. M., M. B. GODDARD, J. MILLS, V. PADRUN, A. ZURN, B. ZIELINSKI, J. FAVRE, J. P. GARDAZ, F. MOSIMANN, J. SAGEN, L. CHRISTENSON & P. AEBISCHER. 1994. Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: a preclinical study for the treatment of cancer pain. Cell Transplant. 3: 355-364.
52. AEBISCHER, P., E. BUCHSER, J. M. JOSEPH, J. FAVRE, N. DE TRIBOLET, M. LYSAGHT, S. RUDNICK & M. GODDARD. 1994b. Transplantation in humans of encapsulated xenogeneic cells without immunosuppression - a preliminary report. Transplantation 58: 1275-1277.
53. SUN, A. M., A. CAI, A. SHI, F. MA, G. M. O'SHEA & J. GHARAPETIAN. 1986. Microencapsulated hepatocytes as a bioartificial liver. Trans. Am. Soc. Artif. Organs XXXII: 39-41.
54. BALLADUR, P., E. CREMA, J. HONIGER, Y. CALMUS, M. BAUDRIMONT, R. DELELO, J. CAPEAU & B. NORDLINGER. 1995. Transplantation of allogeneic hepatocytes without immunosuppression: Long-term survival. Surgery 117: 189-194.
55. BANO, M. C., S. COHEN, K. B. VISSCHER, H. R. ALLCOCK & R. LANGER. 1991. A novel synthetic method for hybridoma cell encapsulation. Biotechnology 9: 468-471.
56. PRAKASH, S. & T. M. S. CHANG. 1996. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat. Med. 2: 883-887.
57. CHANG, P. L. 1995. Nonautologous somatic gene therapy. In Somatic Gene Therapy. P. L. Chang, Ed.: 203-233. CRC Press. Boca Raton, FL.
58. CHANG, P. L., N. SHEN & A. J. WESTCOTT. 1993. Delivery of recombinant gene products with microencapsulated cells in vivo. Hum. Gene Ther. 4: 433-440.
59. AL-HENDY, A., G. HORTELANO, G. S. TANNENBAUM & P. L. CHANG. 1995. Correction of the growth defect in dwarf mice: A novel approach to somatic gene therapy. Hum. Gene Ther. 6: 165-175.
60. HORTELANO, G., A. AL-HENDY, F. A. OFOSU & P. L. CHANG. 1996. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: A novel approach towards allogeneic gene therapy of hemophilia B. Blood 87: 5095-5103.
61. BASTEDO, L., C. J. D. ROSS, M. S. SANDS, G. HORTELANO & P. L. CHANG. Somatic gene therapy on the murine model of mucopolysaccharidosis type VII. In Preparation.
62. PEIRONE, M. A., K. DELANY, J. KWIECIN, A. FLETCH & P. L. CHANG. 1997. Delivery of recombinant gene product to canines with non-autologous microencapsulated cells. Submitted.
63. PEIRONE, M. A., P. FITZGERALD & P. L. CHANG. 1997. Delivery of recombinant gene product to canines using solid core calcium-alginate gel spheres. Submitted.
64. SAGOT, Y., S. A. TAN, E. BAETGE, H. SCHMALBRUCH, A. C. KATO & P. AEBISCHER. 1995. Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur. J. Neurosci. 7: 1313-1322.
65. BARINAGA, M. 1994. Neurotrophic factors enter the clinic. Science 254: 772-774.
66. AEBISCHER, P., N. A.-M. POCHON, B. HEYD, N. DEGLON, J.-M. JOSEPH, A. D. ZURN, E. E. BAETGE, J. P. HAMMANG, M. GODDARD, M. LYSAGHT, F. KAPLAN, A. C. KATO, M. SCHLUEP, L. HIRT, F. REGLI, F. PORCHET & N. DE TRIBOLET. 1996b. Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF. Hum. Gene Ther. 7: 851-860.
67. BRINKHOUS, K. M. & T. GAMBILL. 1972. Hemophilia A and B, Model no. 12. In Handbook: Animal Models of Human Disease. Fasc. 1. T. C. Jones & D. B. Hackel, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
68. DODDS, W. J. 1977. Von Willebrand's disease, Model no. 110. In Handbook: Animal Models of Human Disease, Fasc. 6 T. C. Jones, D. B. Hackel & G. Migaki, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
69. SHULL, R. M., R. J. MUNGER, E. SPELLACY, C. W. HALL, G. CONSTANTOPOULOS & E. F. NEUFELD. 1983. Mucopolysaccharidosis I, Model no. 264. In Handbook: Animal Models of Human Disease, Fasc. 12. C. C. Capen, D. B. Hackel, T. C. Jones & G. Migaki, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
70. HARTLEY, W. J. & B. R. H. FARROW. 1982. Gaucher's disease, Model no 241. In Handbook: Animal Models of Human Disease, Fasc. 11. C. C. Capen, D. B. Hackel, T. C. Jones & G. Migaki, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
71. SANDEFELDT, E., J. F. CUMMINGS, A. DE LAHUNTA, G. BJORCK & L. P. KROOK. 1977. Infantile spinal muscular atrophy, Werdnig-Hoffman disease, Model no. 99. In Handbook: Animal Models of Human Disease, Fasc. 6. T. C. Jones, D. B. Hackel & G. Magaki, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
72. CORK, L. C., J. W. GRIFFIN, R. J. ADAMS & D. L. PRINCE. 1981. Motor neuron disease: spinal muscular atrophy and amyotrophic lateral sclerosis, Model no. 213. In Handbook: Animal Models of Human Disease. Fasc. 10. C. C. Capen, D. B. Hackel, T. C. Jones & G. Migaki, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
73. OWEN, C. A. JR. & J. LUDWIG. 1982. Wilson's disease, Model no. 249. In Handbook: Animal Models of Human Disease, Fasc. 11. C. C. Capen, D. B. Hackel, T. C. Jones & G. Magaki, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
74. BRAUND, K. G., R. E. MCKERRELL, M. TOIVIO-KINNUCAN, J. R. MEHTA & D. M. VAUGHN. 1989. Muscular dystrophy, Model no. 366. In Handbook: Animal Models of Human Disease. Fasc. 17. C. C. Capen, T. C. Jones & G. Migaki, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
75. MCGAVIN, M. D. 1975. Muscular dystrophy, Model no. 51. In Handbook: Animal Models of Human Disease, Fasc. 4. T. C. Jones & D. B. Hackel, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
76. HOWELL, J. MCC., S. R. GOONERATNE & J. M. GAWTHORNE. 1985. Wilson's disease, Model no. 307. In Handbook: Animal Models of Human Disease, Fasc. 14. C. C. Capen, T. C. Jones & G. Migaki, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
77. MILLER, J. M. 1975. Malignant lymphoma, Model no. 56. In Handbook: Animal Models of Human Disease, Fasc. 4, T. C. Jones & D. B. Hackel, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
78. HUNT, R. D. & L. V. MELENDEZ. 1975. Malignant lymphoma, Model no. 60. In Handbook: Animal Models of Human Disease, Fasc. 5. T. C. Jones & D. B. Hackel, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
79. STRANDBERG, J. D. & D. G. GOODMAN. 1975. Breast cancer, Model no. 54. In Handbook: Animal Models of Human Disease. Fasc. 5. T. C. Jones & D. B. Hackel, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
80. LETVIN, N. L. & N. W. KING. 1984. Acquired immune deficiency syndrome, Model no. 291. In Handbook: Animal Models of Human Disease. Fasc. 13. C. C. Capen, D. B. Hackel, T. C. Jones & G. Migaki, Eds. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, D. C.
81. YAMANAKA, S., M. D. JOHNSON, A. GRINBERG, H. WESTPHAL, J. N. CRAWLEY, M. TANIIKE, K. SUZUKI & R. L. PROIA. 1994. Targeted disruption of the Hexa gene results in mice with biochemical and pathological features of Tay-Sachs disease. Proc. Natl. Acad. Sci. USA 91: 9975-9979.
82. FINGER, S., R. P. HEAVENS, D. J. S. SIRINATHSINGHJI, M. R. KUEHN & S. B. DUNNETT. 1988. Behavioral and neurochemical evaluation of a transgenic mouse model of Lesch-Nyhan syndrome. J. Neurol. Sci. 86: 203-213.
83. CHANG, P. L., G. HORTELANO, M. TSE & D. E. AWREY. 1994. Growth of recombinant fibroblasts in alginate microcapsules. Biotech. Bioeng. 43: 925-933.